The North America home healthcare market size accounted for USD 75.59 billion in 2025 and is predicted to increase from USD 81.41 billion in 2026 to approximately USD 158.72 billion by 2035, expanding at a CAGR of 7.7% from 2026 to 2035. Increasing ageing populations, long-term disease prevalence, and growing desire for convenience and autonomy mean that healthcare-at-home models are transformative services, which drive the growth of the market.
Home healthcare workers provide hands-on chronic care and individual assistance to clients with infirmities or other long-term conditions. Home healthcare workers employed by a home care agency may be self-employed independent contractors employed directly by patients. Home health care delivers solutions in the homes of aging patients to lower the effects of disease or incapacity or to enhance and maintain health. Home health care is a limited medical and therapeutic service provided in a patient’s home. The care is offered by licensed professionals and follows individualized treatment plans. It enables the care team to see the patients’ day-to-day experiences, which supports tweaking treatment plans to best suit their patients' requirements. Home health care provides a vital lifeline for patients requiring medical care and support while remaining in the comfort and ease of their own home.
Hospital-at-home programs deliver precise, hospital-driven care at home using remote monitoring, wearables, artificial intelligence, and telehealth platforms, integrated with in-person care. This care model enhances patient satisfaction, reduces expenses and readmissions, and lowers hospital-related complications. It offers remote patient monitoring (RPM) and telemedicine, which have potentially enhanced access to care and have been instrumental in supporting HaH programs. The growing adoption of HaH services globally, driven by challenges in traditional hospitals and a significant focus on enhancing patient experiences and results, emphasizes the significance of progressive technology in creating acute-level care closer to home.
By component, the services segment contributed the largest North America home healthcare market share of 58% in 2025 as home healthcare services remove the requirement for travel to healthcare facilities, creating significant healthcare treatments, diagnostic tests, and therapeutic interventions more reachable and convenient. Patients receive appropriate care in the comfort of their homes, lowering logistical complexities and enhancing adherence to prescribed treatment routines.
By indication, the diabetes & kidney disorders segment contributed the largest market share of 18%, home care approaches for individuals suffering from type 2 diabetes mellitus provide advanced glycemic control compared to hospital care. Home care has become an efficient substitute for traditional hospital care for treating diabetes in older adults. It avoids hospitalizations and reduces infection challenges by offering professional medical care.
By service type, the skilled nursing services segment held a significant share of 30% in the North America home healthcare market, as the most significant advantage of 24-hour skilled nursing is that patients are constantly surrounded by doctors, registered nurses, and professional caregivers. Skilled nursing services are sometimes home to specialist doctors who care for residents with unique requirements.
By payer, the Medicare/Medicaid segment contributed the largest market share of 40%, as Medicaid supports covering medical expenses for aging patients. Medicaid provides advantages not normally covered by Medicare, such as nursing home care and targeted care services.
By delivery mode, the in‑home visit segment contributed the largest North America home healthcare market share of 55%, home visits enable individuals to receive healthcare attention and help in the safety of their own homes, removing the requirement for hospitalization or recurrent visits to healthcare services. Home health care offers tailored care plans that cater to targeted patient needs, preferences, and surroundings.
The four organizations in this market dominate the North America home healthcare market. Meanwhile, Abbott Laboratories is a frontrunner in continuous glucose monitoring (CGM) technology. Medtronic, significant player in remote monitoring, heart health devices, and insulin pumps. 3M Health Care specializes in progressive wound care and healthcare supplies for home use. Omron Healthcare significantly focuses on targeted care, hospice, and home health solutions.
By Component
By Indication
By Application
By End User
By Payer
By Delivery Mode
